Conferences
28–29 April 2010, Hilton San Diego Resort, San Diego, CA, USA
HCV Drug Discovery
It is an exciting time for the field of HCV antivirals. Viral protease and polymerase inhibitors are in late stage clinical trials, as are combinations of them, suggesting an interferon-free drug cocktail to treat HCV may one day be possible. Progress is also being made on small molecule drug candidates that inhibit host proteins involved in the maturation/processing of HCV particles.
Join fellow drug discovery chemists for one and a half days of presentations, posters, roundtable and panel discussions plus plenty of networking time to stay abreast of this burgeoning area and hear the latest medicinal chemistry optimizations and clinical trial strategies and progress of small molecule drug candidates targeting HCV infection.
Topics Presented:
-
Protease Inhibitors
-
Non-nucleoside and Nucleoside Polymerase Inhibitors
-
Inhibiting Viral Structural Proteins
-
Targeting Cellular/Host Proteins
-
Combination Strategies
